Cadralazine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C02DB04
CAS registry number (Chemical Abstracts Service)
0064241-34-5
Chemical Formula
C12-H21-N5-O3
Molecular Weight
283
Therapeutic Categories
Antihypertensive agent
Vasodilator
Chemical Name
Ethyl 6-[ethyl(2-hydroxypropyl)amino]-3-pyridazinecarbazate
Foreign Names
- Cadralazinum (Latin)
- Cadralazin (German)
- Cadralazine (French)
- Cadralazina (Spanish)
Generic Names
- Cadralazina (OS: DCIT)
- Cadralazine (OS: DCF, JAN, BAN)
- ISF 2469 (IS: ISF)
- Cadralazine (PH: JP XV)
Brand Name
- Cadral
Novartis, Japan
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
